INHIBITION OF THE METABOLISM OF CYCLOSPORINE BY HUMAN LIVER-MICROSOMES BY FK506

被引：20
|
作者：
BURKE, MD
OMAR, G
THOMSON, AW
WHITING, PH
机构：
[1] UNIV ABERDEEN,SCH MED,DEPT PATHOL,IMMUNOPATHOL LAB,ABERDEEN AB9 2ZD,SCOTLAND
[2] UNIV ABERDEEN,SCH MED,DEPT CLIN BIOCHEM,ABERDEEN AB9 2ZD,SCOTLAND
来源：
TRANSPLANTATION | 1990年 / 50卷 / 05期
关键词：
D O I：
10.1097/00007890-199011000-00035
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：901 / 902
页数：2
相关论文
共 50 条
  • [21] THE ANTIMICROBIAL ACTIVITIES OF CYCLOSPORINE, FK506, AND RAPAMYCIN
    HIGH, KP
    TRANSPLANTATION, 1994, 57 (12) : 1689 - 1700
  • [22] METABOLISM OF DIAZEPAM IN HUMAN LIVER-MICROSOMES
    WANDEL, C
    BOCKER, R
    BROWNE, A
    BOHRER, H
    MARTIN, E
    ANESTHESIOLOGY, 1994, 81 (3A) : A394 - A394
  • [23] THE METABOLISM OF TRAMADOL BY HUMAN LIVER-MICROSOMES
    PAAR, WD
    FRANKUS, P
    DENGLER, HJ
    CLINICAL INVESTIGATOR, 1992, 70 (08): : 708 - 710
  • [24] AMIODARONE METABOLISM IN HUMAN LIVER-MICROSOMES
    HA, HR
    WYSS, PA
    STIEGER, B
    MEIER, PJ
    MEYER, UA
    FOLLATH, F
    FASEB JOURNAL, 1992, 6 (05): : A1845 - A1845
  • [25] Effects of cyclosporine or FK506 in chronic colitis
    Aiko, S
    Conner, EM
    Fuseler, JA
    Grisham, MB
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 280 (02): : 1075 - 1084
  • [26] FK506 AND CYCLOSPORINE - SIMILAR NEPHROTOXIC EFFECTS
    STILLMAN, IE
    ANDOH, TF
    BENNETT, WM
    ROSEN, S
    LABORATORY INVESTIGATION, 1995, 72 (01) : A161 - A161
  • [27] MOLECULAR-MODE OF ACTION OF CYCLOSPORINE AND FK506 IN HUMAN THYMOCYTES
    REEM, GH
    JOURNAL OF AUTOIMMUNITY, 1992, 5 : 159 - 165
  • [28] HUMAN P-GLYCOPROTEIN TRANSPORTS CYCLOSPORINE-A AND FK506
    SAEKI, T
    UEDA, K
    TANIGAWARA, Y
    HORI, R
    KOMANO, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (09) : 6077 - 6080
  • [29] CYCLOSPORINE AND FK506 INHIBITION OF MURINE MAST-CELL CYTOKINE PRODUCTION
    HATFIELD, SM
    ROEHM, NW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 260 (02): : 680 - 688
  • [30] TACROLIMUS (FK506) VERSUS CYCLOSPORINE IN PREVENTION OF LIVER ALLOGRAFT-REJECTION
    MOORE, R
    LORD, R
    LANCET, 1994, 344 (8927): : 948 - 948
12345